Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs (Q40132445)

17 September 2017

title

Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs (English)

1 reference

17 September 2017

1 reference

whole genome sequencing

1 reference

Ding XR

1

1 reference

17 September 2017

Yang J

2

1 reference

17 September 2017

Sun DC

3

1 reference

17 September 2017

Lou SK

4

1 reference

17 September 2017

Wang SQ

5

1 reference

17 September 2017

publication date

15 May 2007

1 reference

The Pharmacogenomics Journal

17 September 2017

published in

1 reference

17 September 2017

volume

8

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

61-70

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500459

17 September 2017

exact match

0 references

cites work

Hepatitis B virus biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Hepatitis B virus replication: novel roles for virus-host interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Virology. The X files--one step closer to closure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Localization of HSP90 binding sites in the human hepatitis B virus polymerase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Statins inhibit HIV-1 infection by down-regulating Rho activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

The Src Family Kinase c-Yes Is Required for Maturation of West Nile Virus Particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Differential cellular gene expression induced by hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Structure and function of S-adenosylhomocysteine hydrolase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

5'-terminal cap structure in eucaryotic messenger ribonucleic acids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Alpha/Beta-hydrolase fold enzymes: structures, functions and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

A new fluorescent quantitative polymerase chain reaction technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500459

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500459

1 reference

17 September 2017

1 reference